These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10934161)

  • 1. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
    Agarwal S; Mathur M; Srivastava A; Ralhan R
    Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.
    Baral R; Patnaik S; Das BR
    Eur J Oral Sci; 1998 Oct; 106(5):907-13. PubMed ID: 9786319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
    Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
    J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1998 Aug; 79(4):370-5. PubMed ID: 9699529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
    Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
    Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells.
    Bull EK; Chakrabarty S; Brodsky I; Haines DS
    Oncogene; 1998 Apr; 16(17):2249-57. PubMed ID: 9619834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
    Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
    Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into p53 protein stabilisation in oral squamous cell carcinoma.
    Partridge M; Kiguwa S; Emilion G; Pateromichelakis S; A'Hern R; Langdon JD
    Oral Oncol; 1999 Jan; 35(1):45-55. PubMed ID: 10211310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
    Landers JE; Cassel SL; George DL
    Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India.
    Kannan K; Munirajan AK; Krishnamurthy J; Bhuvarahamurthy V; Mohanprasad BK; Panishankar KH; Tsuchida N; Shanmugam G
    Int J Oncol; 1999 Dec; 15(6):1133-6. PubMed ID: 10568819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective compartmentalization of different mdm2 proteins within the nucleus.
    Maxwell SA
    Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and MDM2 expression in oral squamous cell carcinoma.
    Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
    Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
    Ng IO; Lam KY; Ng M; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer.
    Pande P; Soni S; Chakravarti N; Mathur M; Shukla NK; Ralhan R
    Cancer Detect Prev; 2001; 25(5):496-501. PubMed ID: 11718456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells.
    Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH
    Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.